Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis

Table 2

Outcome characteristics by cannabis use status, after propensity matching.

	No Cannabis use	Cannabis use	p-value
n	4728	4728
Liver cirrhosis	10.55	8.52	0.0014
Ascites	4.51	2.79	<0.0001
Variceal bleeding	1.57	1.61	0.0258
Hepatorenal syndrome	0.49	0.38	0.4329
Hepatic encephalopathy	0.59	0.40	0.1964
Portal hypertension	2.92	2.07	0.0108
Jaundice	0.53	0.34	0.158
Baveno4 scoring			0.0019
0: No cirrhosis	89.45	91.48
1: Compensated cirrhosis	5.31	4.72
2: Decompensated cirrhosis	5.25	3.81
Mortality	1.65	1.27	0.119
Liver cancer	1.31	1.04	0.2282
Discharge disposition			0.0014
Favourable discharge	80.71	83.27
Unfavourable discharge	19.29	16.73